Patents by Inventor Andrey Edward Voronkov

Andrey Edward Voronkov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triazole derivatives as Wnt signaling pathway inhibitors
    Patent number: 9403812
    Abstract: The present invention relates to compounds of formula I, to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy: Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway and increased presence of nuclear ?-catenin. For example, these may be used in preventing and/or retarding proliferation of tumor cells and metastasis, for example carcinomas such as colon carcinomas.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: August 2, 2016
    Assignee: OSLO UNIVERSITY HOSPITAL HF
    Inventors: Daniel Holsworth, Jo Waaler, Ondrej Machon, Stefan Krauss, Andrey Edward Voronkov
  • TRIAZOLE DERIVATIVES AS WNT SIGNALING PATHWAY INHIBITORS
    Publication number: 20150322057
    Abstract: The present invention relates to compounds of formula I, to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy: Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway and increased presence of nuclear ?-catenin. For example, these may be used in preventing and/or retarding proliferation of tumor cells and metastasis, for example carcinomas such as colon carcinomas.
    Type: Application
    Filed: June 29, 2015
    Publication date: November 12, 2015
    Inventors: Daniel Holsworth, Jo Waaler, Ondrej Machon, Stefan Krauss, Andrey Edward Voronkov
  • Triazole derivatives as Wnt signaling pathway inhibitors
    Patent number: 9096587
    Abstract: The present invention relates to compounds of formula (I), to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy: Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway and increased presence of nuclear ?-catenin. For example, these may be used in preventing and/or retarding proliferation of tumor cells and metastasis, for example carcinomas such as colon carcinomas.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: August 4, 2015
    Assignee: OSLO UNIVERSITY HOSPITAL HF
    Inventors: Daniel Holsworth, Jo Waaler, Ondrej Machon, Stefan Krauss, Andrey Edward Voronkov
  • TRIAZOLE DERIVATIVES AS WNT SIGNALING PATHWAY INHIBITORS
    Publication number: 20140031374
    Abstract: The present invention relates to compounds of formula (I), to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy: Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway and increased presence of nuclear ?-catenin. For example, these may be used in preventing and/or retarding proliferation of tumor cells and metastasis, for example carcinomas such as colon carcinomas.
    Type: Application
    Filed: December 8, 2011
    Publication date: January 30, 2014
    Applicant: OSLO University Hospital, HF
    Inventors: Daniel Holsworth, Jo Waaler, Ondrej Machon, Stefan Krauss, Andrey Edward Voronkov